STOCK TITAN

Kroger Brings Zepbound® KwikPen to Retail Pharmacy, Expanding Access and Savings for Self-Pay Patients

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Kroger (NYSE: KR) announced on March 13, 2026 that Zepbound® KwikPen, Eli Lilly's multi-dose GLP-1 weight-management pen, is now available at participating Kroger pharmacies. For the first time, eligible self-pay patients may access Lilly's KwikPen savings program at retail pharmacy locations. Kroger pharmacists and dietitians will support adherence, counseling, and integrated care.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Reality Check

Price: $74.96 Vol: Volume 9,285,779 vs 20-da...
normal vol
$74.96 Last Close
Volume Volume 9,285,779 vs 20-day average 7,072,464 (relative volume 1.31x) ahead of this access-focused GLP-1 news. normal
Technical Trading above 200-day MA at 67.26, with price 74.96 and within -2.12% of the 52-week high 76.58.

Peers on Argus

KR gained 3.84% while grocery peers were mixed: ACI +2.12%, SFM +4.42%, WMK +1.7...

KR gained 3.84% while grocery peers were mixed: ACI +2.12%, SFM +4.42%, WMK +1.76%, but TGT -1.43% and GO -6.61%. No peers appeared in the momentum scanner, suggesting the move was more company-specific than sector-wide.

Historical Context

5 past events · Latest: Mar 10 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Mar 10 Community support initiative Positive -1.5% Harris Teeter leaders packed 104,000+ meals for local families.
Mar 09 Promotional campaign Positive -1.0% Customer Appreciation Week with digital coupons and special savings.
Mar 05 Earnings and guidance Positive +5.3% Reported 2025 results and issued 2026 guidance for sales, profit, EPS.
Mar 02 Product expansion Positive +1.2% Expanded Private Selection premium meals across multiple store formats.
Feb 24 GLP-1 access programs Positive +2.2% Announced savings programs to lower out-of-pocket GLP‑1 medication costs.
Pattern Detected

KR often trades in line with fundamental and strategic news, with positive reactions to earnings, GLP-1 access initiatives, and product expansions, but community or promotional headlines have occasionally seen short-term pullbacks.

Recent Company History

Over recent months, Kroger highlighted several initiatives, from GLP-1 affordability programs on Feb 24, 2026 to expanded Private Selection meals on Mar 2, 2026, both followed by positive price moves. The Mar 5, 2026 Q4 2025 earnings and 2026 guidance release produced a 5.27% gain, underscoring sensitivity to fundamentals. Customer Appreciation Week and a Harris Teeter community meal event saw modest declines, suggesting less consistent trading around marketing and CSR headlines. Today’s GLP-1 access expansion with Zepbound® KwikPen fits the recent healthcare and weight-management support theme.

Market Pulse Summary

This announcement expands pharmacy access to Zepbound® KwikPen and, for the first time, allows eligi...
Analysis

This announcement expands pharmacy access to Zepbound® KwikPen and, for the first time, allows eligible self-pay patients to use Lilly’s savings program at Kroger retail locations. It builds on Kroger’s broader GLP‑1 strategy, combining pharmacist counseling, virtual nutrition care, and integrated clinic services. Recent history shows multiple initiatives around GLP‑1 affordability and prepared foods. Investors may watch how this program affects pharmacy traffic, cross-selling of fresh foods, and longer-term health and wellness positioning across Kroger’s stores.

Key Terms

glp-1
1 terms
glp-1 medical
"expanding access to high-demand GLP-1 therapies, Zepbound® KwikPen – the newly"
GLP-1 (glucagon-like peptide-1) is a natural hormone in the body that helps regulate blood sugar levels and appetite. Its significance to investors lies in its role as the basis for a class of medications that address conditions like type 2 diabetes and obesity, which are large and growing markets. Advances or investments in GLP-1-based treatments can signal opportunities in healthcare innovation and potentially impact pharmaceutical companies’ growth.

AI-generated analysis. Not financial advice.

CINCINNATI, March 13, 2026 /PRNewswire/ -- Today The Kroger Co. (NYSE: KR) and The Kroger Family of Pharmacies announced that as part of its continued commitment to expanding access to high-demand GLP-1 therapies, Zepbound® KwikPen – the newly launched, multi-dose delivery option of Eli Lilly's weight-management medication – is now available at participating Kroger pharmacies, bringing patients a more convenient option for obtaining their medication.

Savings at the Pharmacy Counter

The Kroger Family of Pharmacies honor manufacturer-sponsored programs, including Lilly's KwikPen Self-Pay Savings Card for Zepbound®, according to each program's eligibility requirements and terms and conditions. For eligible patients, these programs may help lower out-of-pocket costs. This marks the first time self-pay patients may be eligible for Lilly's savings program for this product at a retail pharmacy location.

Our pharmacy associates also support patients in navigating all available payment options, including insurance benefits, manufacturer programs and discount cards. This empowers patients to choose the pathway that works best for them. Insurance coverage and pricing vary by individual.

"Our customers and communities want affordable, effective weight-management treatment options with real affordability," said Colleen Lindholz, Group Vice President and President of Kroger Health. "Zepbound® KwikPen is now accessible to patients at participating Kroger retail pharmacies, and for the first time this product is available to self-pay patients eligible for Lilly's savings program at a retail pharmacy location."

Support That Extends Beyond the Prescription

Patients filling GLP-1 prescriptions at Kroger Family of Pharmacies have access to a range of services designed to support adherence, education, and long-term health outcomes, including:

  • Personalized pharmacist counseling on how GLP-1 medications work, what to expect, and how to manage side effects
  • Virtual nutrition care from registered dietitians to help patients build sustainable, individualized lifestyle plans
  • Integrated care connecting pharmacy teams with The Little Clinic locations and provider services, as elected by patients, supporting continuity across the full care journey
  • Access to a wide variety of fresh, protein- and fiber-rich foods, an advantage unique to Kroger, where patients can fill their prescription and support their nutrition goals in a single visit
  • Ongoing referrals to dietitians and other healthcare providers, when appropriate, to reinforce a holistic, long-term approach to weight management

Together, these services reflect Kroger's mission to make care more accessible, affordable, and patient-centered — beginning at the pharmacy counter and extending throughout the health journey.

*Zepbound® KwikPen is a prescription medication. A valid prescription from a licensed healthcare provider is required. Availability and eligibility for savings programs may vary.

About Kroger

At The Kroger Co. (NYSE: KR), we are dedicated to our Purpose: To Feed the Human Spirit™. We are, across our family of companies, more than 400,000 associates who serve over 11 million customers daily through an eCommerce experience and retail food stores under a variety of banner names, serving America through food inspiration and uplift, and creating #ZeroHungerZeroWaste communities. To learn more about us, visit our newsroom and investor relations site.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kroger-brings-zepbound-kwikpen-to-retail-pharmacy-expanding-access-and-savings-for-self-pay-patients-302713400.html

SOURCE The Kroger Co.

FAQ

Is Zepbound KwikPen available at Kroger pharmacies (KR) as of March 13, 2026?

Yes — Zepbound KwikPen is available at participating Kroger pharmacies as of March 13, 2026. According to the company, Kroger is offering the newly launched multi-dose delivery option in select retail pharmacy locations to expand patient access.

Can self-pay patients use Lilly's KwikPen savings card at Kroger (KR)?

Potentially yes — eligible self-pay patients may use Lilly's KwikPen savings card at participating Kroger pharmacies. According to the company, eligibility depends on each program's terms and patients should verify requirements and availability at the pharmacy counter.

What patient support services does Kroger (KR) offer for GLP-1 prescriptions?

Kroger offers pharmacist counseling, virtual nutrition care, integrated Little Clinic connections, and referrals to dietitians. According to the company, these services aim to support adherence, side-effect management, and long-term weight-management plans for patients.

How does Kroger (KR) help patients manage out-of-pocket costs for Zepbound KwikPen?

Kroger assists patients by honoring manufacturer-sponsored programs and helping navigate insurance and discount options. According to the company, pharmacy associates support patients in choosing payment pathways that may lower out-of-pocket costs, subject to eligibility and program terms.

Do all Kroger pharmacies carry Zepbound KwikPen and savings eligibility for KR customers?

No — availability and savings eligibility vary by location and program terms. According to the company, Zepbound KwikPen is available at participating Kroger pharmacies, and customers should check with their local pharmacy about stock and eligibility.
Kroger

NYSE:KR

View KR Stock Overview

KR Rankings

KR Latest News

KR Latest SEC Filings

KR Stock Data

44.32B
556.67M
Grocery Stores
Retail-grocery Stores
Link
United States
CINCINNATI